MedPath

Electronic Patient Reported Outcome Measures (PROMs) in Blood Cancer Patients: A Pilot Study

Not Applicable
Recruiting
Conditions
Haematological malignancy
Cancer - Hodgkin's
Cancer - Leukaemia - Acute leukaemia
Cancer - Leukaemia - Chronic leukaemia
Cancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphoma
Cancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma
Cancer - Myeloma
Cancer - Other cancer types
Blood - Other blood disorders
Registration Number
ACTRN12620000303943
Lead Sponsor
Cabrini Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Prospective arm:
1. Participants with a diagnosis of haematological malignancy (including, but not limited to, myeloma, lymphoma, leukaemia, myelodysplastic and myeloproliferative syndromes), attending the study centre
2. In receipt of treatment for their haematological malignancy during the twelve-month study period (including, but not limited to, parenteral chemotherapy and immunotherapy, oral chemotherapy/disease directed therapy or regular blood product transfusions)

Retrospective arm:
1. Participants with a diagnosis of haematological malignancy (including, but not limited to, myeloma, lymphoma, leukaemia, myelodysplastic and myeloproliferative syndromes)
2. Attended the study centre between 28/05/19 - 27/05/2020 for treatment of their haematological malignancy

Exclusion Criteria

For both prospective and retrospective arms, patients who are unable to speak or write the English language are not eligible for participation in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage change in referrals to allied health services (specifically psychology, social work, dietetics and exercise physiology), by comparing prospective study data against existing data on referrals from the same twelve-month period of the previous year[12 months after commencement of the study period];Acceptability of the electronic PROMs to participants, as determined by qualitative data from a 'satisfaction' survey. <br><br>The electronic PROMs is a questionnaire designed specifically for the project. It includes the National Comprehensive Cancer Network's 'Distress Thermometer and Problem List', a validated screening tool, with additional, non-validated questions to screen for nutritional status and physical activity.<br><br>The satisfaction survey is designed specifically for the project. [12 months after commencement of the study period]
Secondary Outcome Measures
NameTimeMethod
Optimal time points for completion electronic PROMS based on completion rates and qualitative data from PROMS and satisfaction surveys[Assessed 12 months post commencement of study period]
© Copyright 2025. All Rights Reserved by MedPath